Target intelligence / Profile preview

Pattern recognition and endocytic receptors on antigen-presenting cells

Molecular classification
Receptor, Other
01

Overview

Pattern recognition and endocytic receptors on antigen-presenting cells (APCs) comprise a broad functional class of proteins, including Toll-like receptors (TLRs), C-type lectin receptors (CLRs), and NOD-like receptors (NLRs), that identify pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) (Kawai & Akira, 2011). These receptors are essential for the innate immune system's ability to sense infection or tissue damage and initiate inflammatory signaling pathways (Janeway & Medzhitov, 2002). Endocytic receptors within this group, such as the mannose receptor (CD206) and DEC-205, are specialized for the uptake of antigens, facilitating their processing and presentation to T cells to trigger adaptive immunity (Figdor et al., 2002). In drug development, specific members of this class are targeted by agonists to act as vaccine adjuvants or by antagonists to treat chronic inflammatory and autoimmune diseases (Kastenmüller et al., 2014). For example, TLR7/8 agonists like imiquimod are used topically for skin malignancies, while TLR4 ligands are incorporated into vaccine formulations to boost immunogenicity. Because this term describes a wide-ranging group of receptors with distinct structures and signaling mechanisms, it is considered a functional category rather than a single specific therapeutic target.

Other names
Pattern recognition receptorsPRRsEndocytic receptorsInnate immune receptorsAntigen-presenting cell receptors
02

Mechanism of action

Activation or inhibition of specific innate immune sensing pathways and antigen uptake mechanisms to modulate the immune response.

03

Biological functions

Immune responseAntigen presentationSignal transductionOther
04

Disease associations

InfectionInflammationCancerOther
05

Safety considerations

Cytokine release syndromeSystemic inflammatory response syndromeInduction of autoimmunityInjection site reactions
06

Interacting drugs

Imiquimod

6 more in the full profile.

07

Biomarkers

CD80 expressionCD86 expressionMHC class II expressionPro-inflammatory cytokine levels (e.g., TNF, IL-6, IL-12)Type I Interferon levels

Beyond the preview

Go deeper on Pattern recognition and endocytic receptors on antigen-presenting cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pattern recognition and endocytic receptors on antigen-presenting cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call